Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators
and regulons
. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulon that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows regulated by Mutation KIAA1324L_code_potential_somatic
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-11500 | KIAA1324L | down-regulates | PAX7 | represses | R-3697 | 3 | 1 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)AMG-780, MEDI-3617, TREBANANIB, VANUCIZUMAB, FARICIMAB, CVX-060, NESVACUMAB |
CMF-11501 | KIAA1324L | down-regulates | GATA6 | represses | R-1253 | 18 | 1 | Drugs (9) Regulator Drugs (0)Regulon Drugs (9)AMG-780, MEDI-3617, ENIBARCIMAB, TREBANANIB, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-11502 | KIAA1324L | down-regulates | TLX2 | represses | R-1571 | 25 | 1 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)BEVACIZUMAB, CONBERCEPT, AMG-780, MEDI-3617, PEGAPTANIB SODIUM, F16SIP 131I, TREBANANIB, PEGAPTANIB OCTASODIUM, MUPARFOSTAT, F16IL2, VANUCIZUMAB, RANIBIZUMAB, FARICIMAB, CVX-060, ABICIPAR PEGOL, NESVACUMAB, AFLIBERCEPT, BROLUCIZUMAB |